Increased incidence of co-infection in critically ill patients with influenza
Co-infection is frequently seen in critically ill patients with influenza, although the exact rate is unknown. We determined the rate of co-infection, the risk factors and the outcomes associated with co-infection in critically ill patients with influenza over a 7-year period in 148 Spanish intensive care units (ICUs).
This was a prospective, observational, multicentre study. Influenza was diagnosed using the polymerase chain reaction. Co-infection had to be confirmed using standard bacteriological tests. The primary endpoint of this analysis was the presence of community-acquired co-infection, with secondary endpoints including ICU, 28-day and hospital mortality.
Of 2901 ICU patients diagnosed with influenza, 482 (16.6 %) had a co-infection. The proportion of cases of co-infection increased from 11.4 % (110/968) in 2009 to 23.4 % (80/342) in 2015 (P < 0.001). Compared with patients without co-infection, patients with co-infection were older [adjusted odds ratio (aOR) 1.1, 95 % confidence interval 1.1–1.2; P < 0.001] and were more frequently immunosuppressed due to existing HIV infection (aOR 2.6 [1.5–4.5]; P < 0.001) or preceding medication (aOR 1.4 [1.1–1.9]; P = 0.03). Co-infection was an independent risk factor for ICU mortality (aOR 1.4 [1.1–1.8]; P < 0.02), 28-day mortality (aOR 1.3 [1.1–1.7]; P = 0.04) and hospital mortality (aOR 1.9 [1.5–2.5]; P < 0.001).
Co-infection in critically ill patients with influenza has increased in recent years. In this Spanish cohort, age and immunosuppression were risk factors for co-infection, and co-infection was an independent risk factor for ICU, 28-day and hospital mortality.
KeywordsInfluenza Co-infection Risk factors Outcome Intensive care
- 6.Giles C, Shuttleworth EM (1957) Postmortem findings in 46 influenza deaths. Lancet (London, England) 273:1224–5Google Scholar
- 9.http://vgripe.isciii.es/gripe/inicio.do. Accessed 20 June 2016
- 16.Martin-Loeches I, Lisboa T, Rhodes A, et al. (2010) Use of corticosteroid therapy in patients affected by severe pandemic (H1N1) V influenza A infection. Intensive Care Med. pp S319–S319Google Scholar
- 24.Muthuri SG, Venkatesan S, Myles PR et al (2014) Effectiveness of neuraminidase inhibitors in reducing mortality in patients admitted to hospital with influenza A H1N1pdm09 virus infection: a meta-analysis of individual participant data. Lancet Respir Med 2:395–404. doi:10.1016/S2213-2600(14)70041-4 CrossRefPubMedGoogle Scholar
- 26.(2014) NICE. National Institute for Health and Care Excellence. Pneumonia (including community acquired pneumonia). http://www.nice.org.uk/guidance/cg191. Accessed 20 June 2016